Brief: Icecure Reports Financial & Operational Results For The Nine Months Ended September 30, 2025
Icecure Medical Ltd ICCM.O: ICECURE REPORTS FINANCIAL & OPERATIONAL RESULTS FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2025 ICECURE MEDICAL: DEMAND FOR PROSENSE SYSTEMS EXPECTED TO ACCELERATE IN 2026 Source text: ID:nPn5SC7jWa Further company coverage: ICCM.O
Recent news on Icecure Medical
See all newsIcecure Medical Ltd reports results for the quarter ended June 30 - Earnings Summary
Israel's IceCure Medical H1 revenue rises on higher system, probe sales
Brief: Icecure Sio Petitions Nccn To Include Cryoablation In Breast Cancer Treatment Guidelines, Citing Icecure's FDA Clearance Of Prosense®
NASDAQ RESUMED AT 09:55 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:45 AM